Revenue and earnings declined year-over-year, but cost reductions improved operating results. Regulatory approvals and new partnerships in healthcare, agriculture, and PFAS remediation strengthen future prospects, though continued negative cash flow highlights the need for increased sales or new financing.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.